The Medical Device Adhesive segmentation by application delineates six primary sub‑markets that collectively drive the overall market size. Surgical fixation adhesives, used for wound closure and tissue bonding, represent the largest share at roughly 35 % of total revenue, reflecting high procedural volumes and premium pricing for biocompatible formulations. Wound‑care adhesives, encompassing dressings and barrier films, contribute about 30 % as they address chronic wound management and outpatient care, where cost‑effectiveness and ease of use are critical. Diagnostic device adhesives, employed in biosensor assembly and microfluidic chips, account for 15 % of the market, buoyed by rapid growth in point‑of‑care testing. Drug‑delivery adhesives, which integrate medication release mechanisms, hold 10 % of the market, driven by personalized therapy trends. Orthopedic implant adhesives, used for prosthetic fixation, and cardiovascular device adhesives each capture roughly 5 % of revenue, reflecting niche adoption but high margin potential. Together, these application segments define the market taxonomy and illustrate how each contributes to total market valuation.